dpp-4 inhibitors and glp-1 agonists Specific actions of receptor DPP4 for the treatment of pancreatic β-cell impairments in type 2 diabetes How does sitagliptin work? DPP-4
Description
GIP , GLP-1/GIP

CAUTION: Consult your physician before use if you are pregnant or nursing, taking medications, undergoing laboratory tests, or have a health condition

Understanding your lab landscape before, during, and after GLP-1 therapy initiation is essential for safe, personalized care

Eating a light, low-fat snack before each dose helps considerably
Dementia risk is shaped by decades of vascular, metabolic, sensory, inflammatory, sleep, and behavioral inputs

Though these drugs have been deemed effective in treating T2DM, the Food and Drug Administration (FDA) and some members of the scientific community have questioned the safety of these therapeutics relative to important cardiovascular endpoints
